Tosylmethyl Isocyanide (CAS#36635-61-7) is an important organic sulfonyl isonitrile intermediate. Its molecule contains sulfonyl groups and isonitrile groups, and it has strong electrophilicity and coupling reactivity, occupying a key position in the pharmaceutical industry. Pharmaceutical giants such as Pfizer, Merck, and Novartis have used it in the synthesis of new proteasome inhibitors, ADC drug intermediates, and antibiotic side chain modifications, promoting the development of anti-tumor and targeted therapy fields.
In addition, this product is also applied in the fields of pesticides (intermediates of new insecticides) and materials science (polymer crosslinking agents, biological conjugation reagents). In the global market, the Asia-Pacific region has become a major supply center due to its cost advantage. Europe, driven by environmental protection policies, has consolidated its industry. Russia, under sanctions, has turned to alternative supplies. In the future, with the development of green synthesis technology and the growth in demand in emerging fields such as biomedicine and medical aesthetics, the market for p-methylbenzenesulfonyl methyl isonitrile is expected to continue to expand.
Application in the pharmaceutical industry
Tosylmethyl isocyanide is a key intermediate in the pharmaceutical field. The reactivity of its isonitrile group makes it widely used in anti-tumor drugs (such as proteasome inhibitors), antibiotic side chain modification and ADC drug synthesis. Pfizer, Merck, Novartis and other pharmaceutical companies use it to develop new therapies, promote the innovation of cancer treatment and biological drugs, and occupy a dominant position in the pharmaceutical market.
Major chemical supplier
The global market is dominated by leading enterprises such as Sigma-Aldrich (high-end scientific research monopoly), TCI Chemicals (rapid response), Alfa Aesar (cost leadership), etc. Regional enterprises such as China Pharmtech and India Alembic participate in low-end competition relying on technological or cost advantages. A differentiated supply pattern will be formed.
Regional market Dynamics
The European market is centered on Germany and Switzerland, and the supply chain is shifting to lower cost regions due to the influence of environmental protection policies. Russia relies on alternative supplies such as China due to sanctions, and its domestic production capacity is insufficient and needs international cooperation. Southeast Asia has become a new engine of growth by circumventing regulatory constraints through regional hubs.
Regulation and environmental considerations
With the tightening of global regulation, EU REACH, US EPA and other regulations put forward higher requirements for product safety, and enterprises face high compliance costs. At the same time, policies such as carbon tariffs promote the development of green processes, such as electrochemical synthesis and microfluidic technology, to adapt to the trend of environmental protection.
The prospects of the future
Technological innovation will promote the demand to extend to new fields such as biomedicine and medical aesthetics, and green synthesis processes (such as photocatalysis and enzymatic catalysis) will become the development direction. Under the influence of geopolitical factors, supply chain reconstruction is accelerating, and enterprises need to focus on differentiated product development and regional compliance layout to cope with alternative technology threats and seize market growth opportunities.
Conclusion
The market for Tosylmethyl isocyanide (CAS#36635-61-7) is characterized by a pattern of “high-end technology blockade + mid-to-low-end cost competition”. Driven by global compliance and technological innovation, it is growing steadily. The Asia-Pacific region remains the core growth pole, while Europe needs to deal with green transformation and cost pressure. Russia relies on external technology input. Enterprises need to focus on high-end development (such as nano-reagents), regionalization (such as setting up factories in Southeast Asia), and compliance (completing regulatory certifications ahead of schedule) in order to gain the upper hand in the pharmaceutical and new energy revolution.
XinChem: Your Trusted Global Supplier
XinChem is a globally leading supplier of isonitrile compounds, dedicated to the innovative research and development and large-scale production of Tosylmethyl isocyanide (C9H9NO2S), providing high-performance solutions for the pharmaceutical, materials, and energy industries.
Ⅰ. Technological advantages
XinChem adopts advanced synthetic technology to produce Tosylmethyl isocyanide, ensuring the high purity and stability of Tosylmethyl isocyanide (CAS#36635-61-7). Our production process is designed to minimize impurities while maintaining the integrity of the chemical structure, thereby producing high-quality products that meet the strict requirements of the pharmaceutical and chemical industries. Our advanced quality control system ensures that each batch of products exhibits consistent performance, providing customers with reliable and high-quality products.
Ⅱ. Product advantages
High purity:
The purity of pharmaceutical grade is ≥99.6% (HPLC), and that of industrial grade is ≥99.0%, meeting the requirements of different scenarios.
Diversified forms:
We offer powder granules and support customized packaging (from 1kg aluminum foil bags to 1-ton IBC drums).
Stable supply:
1kg samples to tonnage orders can be delivered quickly. Packaging is available in bottles and ton bags. The price is highly competitive. Exclusive discounts are available for orders of ten tons.
Ⅲ. Application areas
1.Anti-tumor drug intermediates: As key precursors of proteasome inhibitors (such as bortezomib analogues), they are involved in the synthesis of drugs that inhibit tumor cell proliferation and are used to treat malignant tumors such as multiple myeloma and lymphoma.
2.Antibiotic side chain modification: It is used for the side chain modification of β -lactam antibiotics (such as penicillin and cephalosporins) to enhance the antibacterial activity of the drug, expand the antibacterial spectrum or improve drug resistance.
3.Biopharmaceuticals and targeted therapy: As a linker in ADC drugs (antibody-drug conjugates), it specifically couples the isonitrile group with the lysine residue of the antibody to achieve precise delivery of chemotherapy drugs and reduce toxicity to healthy cells.
Ⅳ. Service support
1.Logistics support: to achieve rapid delivery in the Eurasian market, support air and land transportation.
2.Flexible cooperation: accept small batch trial orders, provide process verification and free sample testing services, reduce customer research and development risk.
Ⅴ. Reasons for choosing XinChem
✅Expertise: 20 years of chemical industry experience.
✅Flexibility: can adapt to any customer needs.
✅Cost performance: The perfect combination of high quality and competitive price.
Contact Us Today!
�� www.xinchem.com
�� sales1@xinchem.com
�� +86 18049800532 (WhatsApp)
Post time: May-16-2025